Accent Microcell

Accent Microcell P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Accent Microcell (ACCENTMIC.NS) as of Oct 21, 2026 is 17.53. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 38.18 — a change of -54.08% (lower).

P/CF

17.53

YoY

-54.08%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Accent Microcell is 2025 17.53 . P/CF (Price-to-Cash-Flow Ratio) of Accent Microcell was 2024 38.18 . It decreases by -54.08% lower compared to the previous year.

The Accent Microcell P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2023
57.12 INR
Jan 1, 2024
38.18 INR
Jan 1, 2025
17.53 INR
The Accent Microcell P/CF history
YEARP/CFYoY
17.53-54.08%
38.18-33.16%
57.12—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Accent Microcell Stock analysis

What does Accent Microcell do? Accent Microcell Ltd develops, processes, and markets a wide range of pharmaceutical products including bulk drugs, formulations in all forms, feed and dietary supplements, and healthcare products across allopathic, ayurvedic, umami, homeopathic, and other branches. The company manufactures and sells antibiotics, herbal, bacteriological, and biological products, as well as insecticides, pesticides, fungicides, and disinfectants. With over 200 products in its portfolio, Accent Microcell targets therapeutic segments in human and veterinary healthcare, offering both raw materials and finished preparations for diverse medical applications. The company's product range includes microcrystalline cellulose powder and alpha cellulose powder, which are used as pharmaceutical excipients. Accent Microcell Limited deals in all kinds of drugs and medicines, covering various therapeutic areas such as antibiotics, herbal remedies, and veterinary applications. Its business model focuses on manufacturing, importing, and exporting these products to meet demand in multiple healthcare sectors. Accent Microcell Ltd's revenue streams come from selling bulk drugs, pharmaceutical formulations, and healthcare products to distributors, pharmacies, and veterinary suppliers. The company's diverse portfolio of over 200 products ensures steady demand across different therapeutic segments, supporting consistent sales in both human and veterinary healthcare markets. Accent Microcell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Accent Microcell stock

P/CF (Price-to-Cash-Flow Ratio) of Accent Microcell is 17.53 in 2025.

P/CF (Price-to-Cash-Flow Ratio) of Accent Microcell changed from 38.18 to 17.53, representing a -54.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Accent Microcell since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Accent Microcell with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Accent Microcell

All Key Metrics — Accent Microcell